Late-starter sites in randomized controlled trials

被引:7
作者
Haidich, AB
Ioannidis, JPA [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece
[2] Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Clin Care Res, Boston, MA 02111 USA
关键词
enrollment; multicenter randomized controlled trials; clinical sites;
D O I
10.1016/S0895-4356(03)00032-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In a cohort of 14 randomized controlled trials conducted by the Adult AIDS Clinical Trials Group between 1986 and 1999 with a target sample size of >400 (total enrollment 15,531 patients), we evaluated whether "late-starter" sites can make a meaningful contribution to eventual trial accrual. The sites that started recruiting within 5 months from the time the first patient entered the trial were eventually responsible for over 90% of the total enrollment in 11 of the 14 trials. Across the 14 trials some sites, were consistently among the first to start enrollment whereas others were routinely among the last. The late-starter sites are unlikely to make important contributions to eventual trial enrollment in large clinical trials conducted by groups with a fixed number of sites. Protracting administrative efforts to add more sites many months after a multicenter trial has started may not be useful to trial accrual. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:408 / 415
页数:8
相关论文
共 30 条
  • [1] BASS HZ, 1992, J ACQ IMMUN DEF SYND, V5, P215
  • [2] BEARMAN JE, 1974, BIOMETRICS NOTE
  • [3] BENEDICT GW, 1979, CLIN PHARMACOL THER, V25, P685
  • [4] A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    BOZZETTE, SA
    FINKELSTEIN, DM
    SPECTOR, SA
    FRAME, P
    POWDERLY, WG
    HE, WL
    PHILLIPS, L
    CRAVEN, D
    VANDERHORST, C
    FEINBERG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) : 693 - 699
  • [5] PLANNING PATIENT RECRUITMENT - FANTASY AND REALITY
    COLLINS, JF
    WILLIFORD, WO
    WEISS, DG
    BINGHAM, SF
    KLETT, CJ
    [J]. STATISTICS IN MEDICINE, 1984, 3 (04) : 435 - 443
  • [6] SOME ADAPTIVE STRATEGIES FOR INADEQUATE SAMPLE ACQUISITION IN VETERANS-ADMINISTRATION COOPERATIVE CLINICAL-TRIALS
    COLLINS, JF
    BINGHAM, SF
    WEISS, DG
    WILLIFORD, WO
    KUHN, RM
    [J]. CONTROLLED CLINICAL TRIALS, 1980, 1 (03): : 227 - 248
  • [7] Sponsorship, authorship, and accountability.
    Davidoff, F
    DeAngelis, CD
    Drazen, JM
    Hoey, J
    Hojgaard, L
    Horton, R
    Kotzin, S
    Nicholls, MG
    Nylenna, M
    Overbeke, AJPM
    Sox, HC
    Van Der Weyden, MB
    Wilkes, MS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) : 825 - 827
  • [8] ARE CLINICAL-TRIALS A COST-EFFECTIVE INVESTMENT
    DETSKY, AS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (13): : 1795 - 1800
  • [9] Lessons learned from enrollment in the BEST study - A multicenter, randomized trial of group psychosocial support in metastatic breast cancer
    Goodwin, PJ
    Leszcz, M
    Quirt, G
    Koopmans, J
    Arnold, A
    Dohan, E
    Hundleby, M
    Chochinov, HM
    Navarro, M
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (01) : 47 - 55
  • [10] Determinants of patient recruitment in a multicenter clinical trials group: Trends, seasonality and the effect of large studies
    Haidich A.-B.
    Ioannidis J.P.A.
    [J]. BMC Medical Research Methodology, 1 (1) : 1 - 11